Aged care operator, Estia Health, had a significant downgrade last week, Japara & Regis were also sold off, but have since recovered. The downgrade put some negative sentiment over the sector. Cuts to government spending in the long-term will hang over the sector for a while, but most of this is priced in for Japara and Regis, who are our preferred operators. We're maintaining our Add recommendation, with 5-10% upside expected in the short-term as the noise dissipates. Watch the full video below for our view on Volpara Health Technologies, Impedimed, and Reva Medical.